Table 1. Patient characteristics and comorbidities for all patients transferred for possible esophageal perforation, and for patients confirmed to have esophageal perforation upon arrival to our institution.
| Patient characteristics | All patients transferred for suspected esophageal perforation (n=65) | Patients with esophageal perforation (n=41) | Patients without esophageal perforation (n=24) | P value |
|---|---|---|---|---|
| Patient age (years) | 56.0 (44.0–69.0) | 59.0 (48.0–69.0) | 54.0 (36.0–66.0) | 0.27 |
| Gender (female) | 36.9% [24] | 36.6% [15] | 37.5% [9] | 0.94 |
| BMI (kg/m2) | 0.98 | |||
| <18.5 | 4.6% [3] | 4.9% [2] | 4.2% [1] | |
| 18.5–24 | 43.1% [28] | 41.5% [17] | 45.8% [11] | |
| 25–29 | 23.1% [15] | 24.4% [10] | 20.8% [5] | |
| >30 | 27.7% [18] | 26.8% [11] | 29.2% [7] | |
| Unknown | 1.5% [1] | 2.4% [1] | – | |
| Charlson Comorbidity index | 2 [1–4] | 2 [1–4] | 1 [1–2.5] | 0.37 |
| ASA class | 0.01 | |||
| I | 6.2% [4] | 2.4% [1] | 12.5% [3] | |
| II | 27.7% [18] | 17.1% [7] | 45.8% [11] | |
| III | 33.8% [22] | 41.5% [17] | 20.8% [5] | |
| IV | 32.3% [21] | 39.0% [16] | 20.8% [5] | |
| Congestive heart failure | 4.6% [3] | 2.4% [1] | 8.3% [2] | 0.55 |
| Pulmonary hypertension | 1.5% [1] | 2.4% [1] | 0.0% [0] | >0.99 |
| CVA or TIA | 3.1% [2] | 4.9% [2] | 0.0% [0] | 0.53 |
| Dementia | 1.5% [1] | 2.4% [1] | 0.0% [0] | >0.99 |
| Cigarette use within 1 year of surgery | 15.4% [10] | 9.8% [4] | 25.0% [6] | 0.15 |
| Alcohol abuse | 0.48 | |||
| None | 80.0% [52] | 75.6% [31] | 87.5% [21] | |
| Current | 16.9% [11] | 19.5% [8] | 12.5% [3] | |
| Prior | 3.1% [2] | 4.9% [2] | 0.0% [0] | |
| Connective tissue disease | 1.5% [1] | 2.4% [1] | 0.0% [0] | >0.99 |
| Peptic ulcer disease | 15.4% [10] | 14.6% [6] | 16.7% [4] | >0.99 |
| Diabetes | 0.76 | |||
| None/diet controlled | 92.3% [60] | 92.7% [38] | 91.7% [22] | |
| Uncomplicated | 6.2% [4] | 4.9% [2] | 8.3% [2] | |
| End-organ damage | 1.5% [1] | 2.4% [1] | 0.0% [0] | |
| Hemiplegia | 1.5% [1] | 2.4% [1] | 0.0% [0] | >0.99 |
| Moderate to severe CKD | 1.5% [1] | 0.0% [0] | 4.2% [1] | 0.37 |
| Solid tumor | 0.70 | |||
| None | 95.4% [62] | 92.7% [38] | 100.0% [24] | |
| Localized | 1.5% [1] | 2.4% [1] | 0.0% [0] | |
| Metastatic | 3.1% [2] | 4.9% [2] | 0.0% [0] | |
| Venous thromboembolism | 1.5% [1] | 2.4% [1] | 0.0% [0] | >0.99 |
| Functional status | 0.03 | |||
| Independent | 76.9% [50] | 70.7% [29] | 87.5% [21] | |
| Partially dependent | 13.8% [9] | 22.0% [9] | 0.0% [0] | |
| Totally dependent | 9.2% [6] | 7.3% [3] | 12.5% [3] | |
| Prior thoracic surgery | 10.8% [7] | 9.8% [4] | 12.5% [3] | 0.70 |
| Prior cardiac surgery | 7.7% [5] | 12.2% [5] | 0.0% [0] | 0.15 |
| Prior abdominal surgery | 38.5% [25] | 34.1% [14] | 45.8% [11] | 0.35 |
Data are presented as median (interquartile range) or % [n]. ASA class, American Society of Anesthesiology Physical Status Classification; BMI, body mass index; CKD, chronic kidney disease; CVA, cerebrovascular accident; IQR, interquartile range; TIA, transient ischemic attack.